Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
BCMA
1:05
Novel CAR-T constructs emerging for patients with multiple myeloma who experience loss of BCMA
Hermann Einsele
• 10 Feb 2023
1:27
Direct detection and isolation of CAR cells from patient samples
Saskia Rösch
• 6 Apr 2022
5:56
Targeting neoantigens in multiple myeloma with CAR T-cell
Angela Krackhard
• 6 Apr 2022
1:38
Adoptive T cell therapies for solid tumors: what are the key challenges?
Chris Klebanoff
• 1 Apr 2022
2:49
Exciting advances in CAR-T and TCR research
David Gilham
• 22 Feb 2021
6:10
Challenges of CAR T-cell therapy for AML: is CD38 the answer?
Lei Yu
• 3 Jun 2021
1:40
Innovations within the CAR T-cell field
Hong Ma
• 19 Feb 2021
4:15
CT053, anti-GPC3 CAR-T and targeting solid tumors
Hong Ma
• 19 Feb 2021
2:19
Progression of CAR-T trials in China
Jianxiang Wang
• 2 Feb 2021
3:21
CAR-T trials to watch in China
Jianxiang Wang
• 2 Feb 2021
4:14
Implementation of CAR T-cell therapy in myeloma: practical and patient-related aspects
Maria-Victoria Mateos
• 3 Feb 2021
5:03
Meta-analysis: anti-BCMA CAR-T in R/R myeloma
Nico Gagelmann
• 1 Sep 2020
4:18
CAR T-cells: current climate & future perspectives in myeloma
Nico Gagelmann
• 1 Sep 2020